PHR — Stock Film
STOCK FILMSCENE 1/11PHR · $10.71
Stock Expert AI presents
PHR
Phreesia, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Phreesia, Inc. A quick introduction.

On the stock market since 2019, it operates in the world of health and science. It has 1,789 employees. Now — the numbers.

on the stock market since 2019
1,789 employees
$662M market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, less than $1 stays as net profit.

This is an established company with proven profits.

THE SALES TREND
Sales are growing, year after year.

Average growth of 23% a year over the last 4 years. Red columns mark years that ended in a loss.

$213.2M
2022
$280.9M
2023
$356.3M
2024
$419.8M
2025
$480.6M
2026
Every quarter, analysts set a profit bar.
How many of the last 8 did the company clear?
8 / 8
EXPECTATIONS MET OR BEATEN
8
Sep 2024
Dec 2024
Mar 2025
May 2025
Sep 2025
Dec 2025
Mar 2026
May 2026
8 TIMES IN THE LAST 8 QUARTERS
It clears the bar, quarter after quarter.
INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
86
very strong

Profit power and business quality lead the class.

FINANCIAL STRENGTH
48
weak

Clearly below the class average.

VALUATION
74
strong

Clearly above the class average — a step short of the very top.

GROWTH
99
very strong

Sales are growing strongly for its sector.

PRICE MOMENTUM
30
very weak

Clearly below the class average.

WORTH WATCHING

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 5 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Fat profit per sale, but shrinking10/10
Heavy investment in the future10/10
WEAK SPOTS
The stock has lost its spark0/10
Executives aren’t buying3/10
Heavy bets against the stock4/10
WORTH WATCHING

Executive Buying: The trades send no strong signal of confidence.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 86% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/3
Sales keep climbing

Over the last 3 years, sales grew about 20% a year on average.

2
THE BRIGHT SIDE · 2/3
Delivers on expectations

It met or beat analyst expectations in 8 of the last 8 quarters — consistency is a promise kept.

3
THE BRIGHT SIDE · 3/3
Analysts’ target sits above today’s price

The average analyst price target is $13.5727% above today’s price.

1
THE RISKS · 1/3
A rich price tag

The company’s market value is 287 times its annual profit. Even a small disappointment could hit the price hard.

2
THE RISKS · 2/3
The stock has lost its spark

Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 30/100. For a turnaround signal, the stock first needs to close the gap with the market.

3
THE RISKS · 3/3
A thin financial cushion

The balance sheet offers little cushion against a rough stretch. Report-card grade: 48/100.

FINALE · THE GRADE
C
0 / 100 · MoonshotScore

On our five-subject report card, PHR sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.

The takeaway: PHR is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film